Revance Therapeutics Inc. buy RudolfL
Start price
04.02.24
/
0%
€4.86
Target price
04.02.25
-
Performance (%)
13.17%
End price
04.03.24
€5.50
Summary
This prediction ended on 04.03.24 with a price of €5.50. The prediction had a final performance of 13.17%. This prediction was marked as speculative and is excluded from RudolfL's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Revance Therapeutics Inc. | - | - |
| iShares Core DAX® | 3.523% | 3.763% |
| iShares Nasdaq 100 | 1.026% | 2.380% |
| iShares Nikkei 225® | -0.063% | 0.000% |
| iShares S&P 500 | 0.557% | 2.222% |
Comments by RudolfL for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.